163 related articles for article (PubMed ID: 23865464)
1. Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary--results from a nationwide clinical audit.
Kiss I; Kiss Z; Ambrus C; Szabó A; Szegedi J; Balla J; Ladányi E; Csiky B; Árkossy O; Török M; Túri S; Kulcsár I;
BMC Nephrol; 2013 Jul; 14():155. PubMed ID: 23865464
[TBL] [Abstract][Full Text] [Related]
2. Trends of elevated parathormone serum titers in hemodialysis patients on intensive therapy for bone disease: a multicenter study.
Karkar A; Sinha AK; Abdelrahman M; Mushtaque F; Awn NM; Qadi Y; Nassar M; Algareeb A; Taha MI; Abdulkader M; Sabry A; Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1166-77. PubMed ID: 25394432
[TBL] [Abstract][Full Text] [Related]
3. Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study.
Kuo TH; Lin WH; Chao JY; Wu AB; Tseng CC; Chang YT; Liou HH; Wang MC
BMC Nephrol; 2019 Jul; 20(1):266. PubMed ID: 31315601
[TBL] [Abstract][Full Text] [Related]
4. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
[TBL] [Abstract][Full Text] [Related]
5. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
6. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
[TBL] [Abstract][Full Text] [Related]
7. Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.
Dang ZH; Tang C; Li GL; Luobu C; Qing D; Ma ZH; Qu JF; Suolang L; Liu LJ
Ren Fail; 2019 Nov; 41(1):636-643. PubMed ID: 31269846
[No Abstract] [Full Text] [Related]
8. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
[TBL] [Abstract][Full Text] [Related]
9. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study.
Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC
BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
[TBL] [Abstract][Full Text] [Related]
11. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
[TBL] [Abstract][Full Text] [Related]
12. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
Shaheen FA; Kurpad R; Al-Sayyari AA; Souqiyyeh MZ; Aljubori H; El Baz T; Kashif W; Tuganbekova S; Kabulbayev K; Jarraya F; Nafar M
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):290-304. PubMed ID: 26997382
[TBL] [Abstract][Full Text] [Related]
13. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
[TBL] [Abstract][Full Text] [Related]
14. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
Ambrus C; Molnar MZ; Czira ME; Rosivall L; Kiss I; Remport A; Szathmari M; Mucsi I
Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
[TBL] [Abstract][Full Text] [Related]
15. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
[TBL] [Abstract][Full Text] [Related]
16. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
Neri L; Kreuzberg U; Bellocchio F; Brancaccio D; Barbieri C; Canaud B; Stuard S; Ketteler M
Nephrol Dial Transplant; 2019 Apr; 34(4):682-691. PubMed ID: 30165528
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve?
Weissheimer R; Bucharles SGE; Truyts CAM; Jorgetti V; Figueiredo AE; Barrett P; Olandoski M; Pecoits-Filho R; Moraes TP
J Bras Nefrol; 2021; 43(2):173-181. PubMed ID: 33538758
[TBL] [Abstract][Full Text] [Related]
18. Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.
Haffner D; Schaefer F
Pediatr Nephrol; 2013 Apr; 28(4):537-45. PubMed ID: 22893310
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis.
Ahmadi F; Salari S; Maziar S; Esfahanian F; Khazaeipour Z; Ranjbarnovin N
Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):41-7. PubMed ID: 23354190
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism.
Ruderman I; Smith ER; Toussaint ND; Hewitson TD; Holt SG
BMC Nephrol; 2018 May; 19(1):113. PubMed ID: 29764395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
